Yet, given the variations in risk based on specific GPVs, such as the established differences in breast cancer risks for the CHEK2 1100delC GPV compared to the CHEK2 I157T GPV genotypes, it is important to account for these differences when estimating risks. The gene discussed is CHEK2; the disease is breast cancer.